ACA
CVS icon

Aptus Capital Advisors’s CVS Health CVS Stock Holding History

Aptus Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.7M Buy
65,442
+50,382
+335% +$3.88M 0.04% 350
2025
Q4 		$1.2M Buy
15,060
+246
+2% +$19.4K 0.01% 539
2025
Q3 		$1.12M Sell
14,814
-1,421
-9% -$97.4K 0.01% 539
2025
Q2 		$1.12M Buy
16,235
+3,813
+31% +$250K 0.01% 510
2025
Q1 		$842K Buy
12,422
+412
+3% +$24.7K 0.01% 538
2024
Q4 		$539K Sell
12,010
-68
-0.6% -$3.81K 0.01% 616
2024
Q3 		$759K Buy
12,078
+865
+8% +$50.5K 0.01% 461
2024
Q2 		$662K Buy
11,213
+19
+0.2% +$1.19K 0.01% 456
2024
Q1 		$893K Buy
11,194
+1,436
+15% +$110K 0.02% 412
2023
Q4 		$770K Sell
9,758
-555
-5% -$39.5K 0.02% 323
2023
Q3 		$720K Buy
10,313
+2,922
+40% +$207K 0.02% 334
2023
Q2 		$511K Sell
7,391
-61
-0.8% -$4.34K 0.01% 323
2023
Q1 		$554K Buy
7,452
+818
+12% +$68.6K 0.01% 312
2022
Q4 		$618K Buy
6,634
+120
+2% +$11.6K 0.02% 326
2022
Q3 		$621K Buy
6,514
+1,551
+31% +$154K 0.01% 303
2022
Q2 		$459K Sell
4,963
-1,353
-21% -$132K 0.01% 287
2022
Q1 		$640K Buy
6,316
+3,457
+121% +$363K 0.02% 281
2021
Q4 		$295K Buy
2,859
+348
+14% +$32.2K 0.01% 317
2021
Q3 		$213K Sell
2,511
-63
-2% -$5.28K 0.01% 346
2021
Q2 		$215K Buy
+2,574
New +$211K 0.01% 350
2019
Q2 		– Sell
-26,107
Closed -$1.41M – 339
2019
Q1 		$1.41M Buy
26,107
+3,401
+15% +$210K 0.24% 97
2018
Q4 		$1.49M Buy
+22,706
New +$1.69M 0.39% 38

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aptus Capital Advisors's CVS Position: Q1 2026 in Review

Aptus Capital Advisors increased its CVS Health (CVS) stake by 335% in Q1 2026, buying an estimated $3.88M and bringing the position to 65,442 shares worth $4.7M. The position accounts for 0.04% of the portfolio, ranked #350.

Aptus Capital Advisors first reported a position in CVS in Q4 2018 and has held it in 22 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Aptus Capital Advisors held 65,442 shares of CVS Health worth $4.7M as of Q1 2026.
  • Aptus Capital Advisors bought 50,382 CVS Health shares in Q1 2026, an estimated $3.88M.
  • CVS Health made up 0.04% of Aptus Capital Advisors's portfolio in Q1 2026, its #350 holding.
  • Aptus Capital Advisors first reported a position in CVS Health in Q4 2018 and has held it in 22 quarters since.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.